×

Coronavirus

Presient Biden to end COVID-19 emergencies on May 11

WASHINGTON — President Joe Biden informed Congress on Monday that he will end the twin national emergencies for addressing COVID-19 on May 11, as most of the world has returned closer to normalcy nearly three years after they were first declared. The move to end the national emergency and ...

US clears updated COVID boosters for kids as young as 5

The U.S. on Wednesday authorized updated COVID-19 boosters for children as young as 5, seeking to expand protection ahead of an expected winter wave. Tweaked boosters rolled out for Americans 12 and older last month, doses modified to target today’s most common and contagious omicron ...

Canada to drop all COVID border restrictions Saturday

Starting this Saturday, people entering the Canadian border by plane, train or automobile will no longer face COVID-19 testing or vaccination requirements or restrictions. The Canadian government officially announced on Monday that it would drop all COVID-19-related border crossing ...

Mercy COVID outbreak continues

TUPPER LAKE — The COVID-19 outbreak at Mercy Living Center is ongoing, with the total number of infected staff and elderly residents increasing by seven over the weekend, but infections so far have not progressed into serious disease for residents or staff, according to Adirondack Health ...

New COVID boosters arrive at Essex County clinics Monday

The Essex County Health Department is offering upgraded booster shots for the Pfizer-BioNTech and Moderna COVID-19 vaccines at the department’s vaccine clinics starting on Monday. The updated boosters, called “bivalent boosters,” add components of recent variants of the coronavirus — ...

US clears updated COVID boosters targeting variants

WASHINGTON — The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days. The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that ...